Table 1

Characteristics of patients between patients with/without nephrotic syndrome

Nephrotic syndromeP values
YesNo
(n=3663)(n=14 652)
n%n%
Age, year0.99
 20–49189051.6756051.6
 50–64104328.5417228.5
 ≥6573019.9292019.9
 Mean (SD)*50.215.849.716.00.14
Gender0.99
 Female152541.6610041.6
 Male213858.4855258.4
Comorbidity
 Diabetes47212.99806.69<0.001
 Hypertension125134.2362524.7<0.001
 Hyperlipidaemia105728.9230515.7<0.001
 Coronary artery disease63617.4174211.9<0.001
 Head injury1173.193682.510.02
 COPD44912.312598.59<0.001
 Depression1905.195313.62<0.001
 Stroke892.434292.930.10
 Dementia371.011471.000.97
 Epilepsy310.85960.660.21
Medication
 Immunosuppressant therapies952.591380.94<0.001
 Biological therapy rituximab with prednisolone†20.0560.040.66
  • Χ2 test.

  • *t-test.

  • †Fisher exact test.

  • COPD, chronic obstructive pulmonary disease.